These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30416068)

  • 21. Evaluation of patient comprehension and quality of consumer medicine information.
    Pongpunna S; Wongtaweepkij K; Pratipanawatr T; Jarernsiripornkul N
    Pharm Pract (Granada); 2022; 20(4):2730. PubMed ID: 36793918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Provision of medicines information in Australian community pharmacies.
    Vitry A; Gilbert A; Mott K; Rao D; March G
    Pharm World Sci; 2009 Apr; 31(2):154-7. PubMed ID: 19229651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment tool for pharmacy drug-drug interaction software.
    Warholak TL; Hines LE; Saverno KR; Grizzle AJ; Malone DC
    J Am Pharm Assoc (2003); 2011; 51(3):418-24. PubMed ID: 21555296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory tests in the clinical risk management of potential drug-drug interactions: a cross-sectional study using drug-dispensing data from 100 Dutch community pharmacies.
    Geerts AF; De Koning FH; De Smet PA; Van Solinge WW; Egberts TC
    Drug Saf; 2009; 32(12):1189-97. PubMed ID: 19916585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of drug information from carton boxes, leaflets and pharmacy personnel: situation analysis in Myanmar.
    Win ZN; Anantachoti P
    Int J Pharm Pract; 2022 Jan; 30(1):52-58. PubMed ID: 34739050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concordance of severity ratings provided in four drug interaction compendia.
    Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Hansten PD; Van Bergen RC; Lipton RB
    J Am Pharm Assoc (2003); 2004; 44(2):136-41. PubMed ID: 15098847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of the quality of information leaflets on hayfever available from general practices and community pharmacies.
    White P; Smith H; Webley F; Frew A
    Clin Exp Allergy; 2004 Sep; 34(9):1438-43. PubMed ID: 15347378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Memory, Perceptions, and Preferences of Multimedia Consumer Medication Information: Experimental Performance and Self-Report Study.
    Monkman H; Kushniruk AW; Borycki EM; Sheets DJ; Barnett J
    JMIR Hum Factors; 2020 Dec; 7(4):e15913. PubMed ID: 33258780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Readability of consumer medication information for intranasal corticosteroid inhalers.
    Roskos SE; Wallace LS; Weiss BD
    Am J Health Syst Pharm; 2008 Jan; 65(1):65-8. PubMed ID: 18159042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials.
    Marcath LA; Coe TD; Hoylman EK; Redman BG; Hertz DL
    BMC Cancer; 2018 Nov; 18(1):1155. PubMed ID: 30466416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consumers' expectations and experiences with chain community pharmacies in Lahore, Pakistan: a qualitative exploratory study.
    Asif U; Saleem A; Masood I; Nawaz M
    Int J Clin Pharm; 2019 Jun; 41(3):813-819. PubMed ID: 31028597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.
    Malone DC; Abarca J; Hansten PD; Grizzle AJ; Armstrong EP; Van Bergen RC; Duncan-Edgar BS; Solomon SL; Lipton RB
    J Am Pharm Assoc (2003); 2004; 44(2):142-51. PubMed ID: 15098848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Email medication counseling services provided by Finnish community pharmacies.
    Pohjanoksa-Mäntylä MK; Kulovaara H; Bell JS; Enäkoski M; Airaksinen MS
    Ann Pharmacother; 2008 Dec; 42(12):1782-90. PubMed ID: 19033478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Typeface legibility of patient information leaflets intended for community-dwelling seniors.
    Chubaty A; Sadowski CA; Carrie AG
    Age Ageing; 2009 Jul; 38(4):441-7. PubMed ID: 19483246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug-drug interactions with risk of QT-prolongation. A epidemiological study in Belgian community pharmacies].
    Vandael E; De WuLf I; Foulon V
    J Pharm Belg; 2016 Dec; (4):14-23. PubMed ID: 30281244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
    Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
    BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of drug-interaction alerts in community pharmacies.
    Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A survey of the quality and accuracy of information leaflets about skin cancer and sun-protective behaviour available from UK general practices and community pharmacies.
    Nicholls S; Hankins M; Hooley C; Smith H
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):566-9. PubMed ID: 19175488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.